Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-17-009907
Filing Date
2017-09-22
Accepted
2017-09-22 13:58:16
Documents
49
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO ANNUAL REPORT f10k2016a3_americanbrivision.htm 10-K/A 263690
2 CERTIFICATION f10k2016a3ex31-1_americanbri.htm EX-31.1 17420
3 CERTIFICATION f10k2016a3ex31-2_americanbri.htm EX-31.2 17844
4 CERTIFICATION f10k2016a3ex32-1_americanbri.htm EX-32.1 6943
5 CERTIFICATION f10k2016a3ex32-2_americanbri.htm EX-32.2 7037
  Complete submission text file 0001213900-17-009907.txt   2307870

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtoo-20160930.xml EX-101.INS 394862
7 XBRL SCHEMA FILE mtoo-20160930.xsd EX-101.SCH 29558
8 XBRL CALCULATION FILE mtoo-20160930_cal.xml EX-101.CAL 23731
9 XBRL DEFINITION FILE mtoo-20160930_def.xml EX-101.DEF 75725
10 XBRL LABEL FILE mtoo-20160930_lab.xml EX-101.LAB 206754
11 XBRL PRESENTATION FILE mtoo-20160930_pre.xml EX-101.PRE 167269
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 333-91436 | Film No.: 171097307
SIC: 2834 Pharmaceutical Preparations